AstraZeneca Ready to Scrap Plans for US Approval of COVID Shot

An AstraZeneca executive said the British drugmaker would consider not submitting its COVID-19 vaccine for approval in the United States if the regulatory process takes too long.
Reuters Health Information

source https://www.medscape.com/viewarticle/970480?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors